Clinical Trial Transparency & Disclosures

MMS helps Sponsors achieve and surpass clinical trial disclosures reporting requirements for clinicaltrials.gov, the European Union Clinical Trials Register (EU-CTR), EU Clinical Trial Information System (EU-CTIS), and other international registries.

Our robust services, processes, and tools allow MMS to be your centralized transparency department with the ability to manage all workflow and clinical data reporting obligations for an entire pipeline.

MMS is an innovator of risk-based clinical trial document anonymization, with industry thought leadership and the use of advanced AI tools to achieve both efficiency and quality in every deliverable. Internal anonymization processes and tools are designed to maximize data utility and protect patient privacy.

Our risk-based dataset anonymization approach protects patient privacy and maximizes the data utility by keeping the risk below our predetermined threshold, and our process is proven to produce high-quality anonymized datasets with less manual effort. The anonymization of each variable is driven by a standard rule set that can be reused across multiple studies.

Our rule-building technology allows MMS to switch rules based on the personal information in each variable. Our tool can anonymize individual patient level data in different data sources, including SAS transport files, SAS7BDAT, Excel, and CSV.

As an industry leader in the creation of lay summaries, MMS develops programs for Sponsors to meet and exceed current and future regulations. With a team of dedicated plain language summary writers, graphic designers, lay reviewers, and project managers, the transparency specialists at MMS are focused on ensuring the success of every plain language summary created.

Our global team enables quick mobilization, 24-hour support, and the ability to scale our services to meet your needs.